Details of the Drug Formulaction

General Information of Drug Formulation (ID: F22013)

• Formulation Name: Valproic acid 250 mg capsule
• Company: Actavis Pharma; Aphena Pharma Solutions-Tennessee; Clinical Solutions Wholesale; Contract Pharmacal; NCS HealthCare of KY, Inc dba Vangard Labs; Physicians Total Care; RemedyRepack

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Valproate	(DMCFE9I)	Epilepsy	8A60-8A68	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Glycerin	(E00026)	753	Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent